Disclaimer:
The Society of Interventional Radiology (SIR) Residents, Fellows and Students (RFS) website is a volunteer-managed site and is not actively monitored or maintained by SIR staff. Information on this website should not be construed as professional advice, legal or otherwise, and does not necessarily represent the views of SIR or SIR Foundation. Questions and concerns about the clinical content of this website can be directed to the RFS web manager at ejkeller607@gmail.com or to SIR communications at comm@sirweb.org.
PURPOSE To evaluate the safety and efficacy of combination therapy (TACE+ sorafenib) in patients with advanced stage HCC. STUDY DESIGN Open-label, non-randomized, single-arm multicenter phase II clinical trial. The primary endpoint was defined as the Read more…
Tell me a little about yourself. I am originally from Seattle. I received my undergrad degree in bioengineering at the University of Washington in Seattle and then spent 4.5 years in an immunology lab at Read more…
